A qualitative study on the facilitators and barriers to adopting the N-of-1 trial methodology as part of clinical practice: potential versus implementation challenges
Purpose To investigate opinions among healthcare stakeholders whether implementation of the N-of-1 trial approach in clinical practice is a feasible way to optimize evidence-based treatment results for unique patients. Methods We interviewed clinicians, researchers, and a patient advocate (n = 13) w...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | International Journal of Qualitative Studies on Health & Well-Being |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/17482631.2024.2318810 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846124693883453440 |
|---|---|
| author | Ilona Wilmont Mark Loeffen Thomas Hoogeboom |
| author_facet | Ilona Wilmont Mark Loeffen Thomas Hoogeboom |
| author_sort | Ilona Wilmont |
| collection | DOAJ |
| description | Purpose To investigate opinions among healthcare stakeholders whether implementation of the N-of-1 trial approach in clinical practice is a feasible way to optimize evidence-based treatment results for unique patients. Methods We interviewed clinicians, researchers, and a patient advocate (n = 13) with an interest in or experience with N-of-1 trials on the following topics: experience with N-of-1, measurement, validity and reliability, informally gathered data usability, and influence on physician-patient relationship. Interviews were analysed using qualitative, thematic analysis. Results The N-of-1 approach has the potential to shift the current healthcare system towards embracing personalized medicine. However, its application in clinical practice carries significant challenges in terms of logistics, time investment and acceptability. New skills will be required from patients and healthcare providers, which may alter the patient-physician relationship. The rise of consumer technology enabling self-measurement may leverage the uptake of N-of-1 approaches in clinical practice. Conclusions There is a strong belief that the N-of-1 approach has the potential to play a prominent role in transitioning the current healthcare system towards embracing personalized medicine. However, there are many barriers deeply ingrained in our healthcare system that hamper the uptake of the N-of-1 approach, making it momentarily only interesting for research purposes. |
| format | Article |
| id | doaj-art-e7c494446eb4449984457700ee5ceccf |
| institution | Kabale University |
| issn | 1748-2623 1748-2631 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | International Journal of Qualitative Studies on Health & Well-Being |
| spelling | doaj-art-e7c494446eb4449984457700ee5ceccf2024-12-13T15:19:02ZengTaylor & Francis GroupInternational Journal of Qualitative Studies on Health & Well-Being1748-26231748-26312024-12-0119110.1080/17482631.2024.23188102318810A qualitative study on the facilitators and barriers to adopting the N-of-1 trial methodology as part of clinical practice: potential versus implementation challengesIlona Wilmont0Mark Loeffen1Thomas Hoogeboom2HAN University of Applied SciencesFysiotherapie LentRadboud university medical center, Radboud Institute for Health SciencesPurpose To investigate opinions among healthcare stakeholders whether implementation of the N-of-1 trial approach in clinical practice is a feasible way to optimize evidence-based treatment results for unique patients. Methods We interviewed clinicians, researchers, and a patient advocate (n = 13) with an interest in or experience with N-of-1 trials on the following topics: experience with N-of-1, measurement, validity and reliability, informally gathered data usability, and influence on physician-patient relationship. Interviews were analysed using qualitative, thematic analysis. Results The N-of-1 approach has the potential to shift the current healthcare system towards embracing personalized medicine. However, its application in clinical practice carries significant challenges in terms of logistics, time investment and acceptability. New skills will be required from patients and healthcare providers, which may alter the patient-physician relationship. The rise of consumer technology enabling self-measurement may leverage the uptake of N-of-1 approaches in clinical practice. Conclusions There is a strong belief that the N-of-1 approach has the potential to play a prominent role in transitioning the current healthcare system towards embracing personalized medicine. However, there are many barriers deeply ingrained in our healthcare system that hamper the uptake of the N-of-1 approach, making it momentarily only interesting for research purposes.http://dx.doi.org/10.1080/17482631.2024.2318810n-of-1 trialsindividual point of care studiessingle case designssingle subject researchpersonalized healthcarepersonal science |
| spellingShingle | Ilona Wilmont Mark Loeffen Thomas Hoogeboom A qualitative study on the facilitators and barriers to adopting the N-of-1 trial methodology as part of clinical practice: potential versus implementation challenges International Journal of Qualitative Studies on Health & Well-Being n-of-1 trials individual point of care studies single case designs single subject research personalized healthcare personal science |
| title | A qualitative study on the facilitators and barriers to adopting the N-of-1 trial methodology as part of clinical practice: potential versus implementation challenges |
| title_full | A qualitative study on the facilitators and barriers to adopting the N-of-1 trial methodology as part of clinical practice: potential versus implementation challenges |
| title_fullStr | A qualitative study on the facilitators and barriers to adopting the N-of-1 trial methodology as part of clinical practice: potential versus implementation challenges |
| title_full_unstemmed | A qualitative study on the facilitators and barriers to adopting the N-of-1 trial methodology as part of clinical practice: potential versus implementation challenges |
| title_short | A qualitative study on the facilitators and barriers to adopting the N-of-1 trial methodology as part of clinical practice: potential versus implementation challenges |
| title_sort | qualitative study on the facilitators and barriers to adopting the n of 1 trial methodology as part of clinical practice potential versus implementation challenges |
| topic | n-of-1 trials individual point of care studies single case designs single subject research personalized healthcare personal science |
| url | http://dx.doi.org/10.1080/17482631.2024.2318810 |
| work_keys_str_mv | AT ilonawilmont aqualitativestudyonthefacilitatorsandbarrierstoadoptingthenof1trialmethodologyaspartofclinicalpracticepotentialversusimplementationchallenges AT markloeffen aqualitativestudyonthefacilitatorsandbarrierstoadoptingthenof1trialmethodologyaspartofclinicalpracticepotentialversusimplementationchallenges AT thomashoogeboom aqualitativestudyonthefacilitatorsandbarrierstoadoptingthenof1trialmethodologyaspartofclinicalpracticepotentialversusimplementationchallenges AT ilonawilmont qualitativestudyonthefacilitatorsandbarrierstoadoptingthenof1trialmethodologyaspartofclinicalpracticepotentialversusimplementationchallenges AT markloeffen qualitativestudyonthefacilitatorsandbarrierstoadoptingthenof1trialmethodologyaspartofclinicalpracticepotentialversusimplementationchallenges AT thomashoogeboom qualitativestudyonthefacilitatorsandbarrierstoadoptingthenof1trialmethodologyaspartofclinicalpracticepotentialversusimplementationchallenges |